Pancreatic Cancer Research

ResearcherChinese Academy of SciencesActive in the last 2 years

Ning Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6705-6541; OpenAlex author ID A5044166963. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
10
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 5

  1. Corrigendum to "Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxa… Last author DOI 10.1016/j.biopha.2026.119213↗
  2. A glycogen derived from sea urchin-Strongylocentyotus internedius shifts macrophages to the M1 phenotype and enhances the anti-pancreatic cancer activity of ge… Co-author DOI 10.3389/fphar.2025.1600349↗
  3. Low molecular weight fucoidan LF2 improves the immunosuppressive tumor microenvironment and enhances the anti-pancreatic cancer activity of oxaliplatin. Last author DOI 10.1016/j.biopha.2024.116360↗
  4. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway. First author DOI 10.1038/s41419-019-2073-4↗
  5. Oleanolic acid potentiates the antitumor activity of 5-fluorouracil in pancreatic cancer cells. Co-author DOI 10.3892/or.2012.1921↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Quanbin Zhang · 3 shared papers, 2024–2026 · strength 0.84
  2. Zhenzhen Deng · 2 shared papers, 2024–2025 · strength 0.51
  3. Zhenzhen Deng · 1 shared paper, 2026 · strength 0.33
  4. Jing Wang · 1 shared paper, 2025 · strength 0.27
  5. Chuanlong Guo · 1 shared paper, 2019 · strength 0.10
  6. Dayong Shi · 1 shared paper, 2019 · strength 0.10
  7. Qi Xu · 1 shared paper, 2019 · strength 0.10
  8. Huaizhi Wang · 1 shared paper, 2019 · strength 0.10
  9. Jianteng Wei · 1 shared paper, 2012 · strength 0.03
  10. Xiukun Lin · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.